Since the implementation of Medical Device Regulation (EU) 2017/745, audits across medical device manufacturers, distributors, and service providers continue to reveal recurring compliance challenges. These issues are rarely isolated failures; rather, they reflect systemic gaps in governance, documentation, and regulatory integration. The following pitfalls represent common themes observed during MDR-focused GMP and quality system audits across the industry.
1. Underestimating the Criticality of Labeling and Translation Processes
Labeling and translation activities are often treated as administrative or downstream tasks rather than critical quality processes. Common gaps include initiating labeling activities before formal approval, insufficient qualification of translation sources, and weak documentation supporting labeling decisions. Under MDR, such gaps pose direct risks to patient safety and regulatory compliance.
2. Inadequate Control of Artwork, Printing, and Line Clearance
Many organizations lack robust controls over artwork versioning, printed material reconciliation, and line clearance activities. The absence of clearly defined procedures for managing excess or obsolete labels and insufficient segregation of labeling activities increases the risk of mix-ups, particularly in reworking and relabeling scenarios.
3. Documentation Practices That Do Not Support Traceability
Incomplete, inconsistent, or poorly structured documentation remains one of the most frequent audit observations. Missing reconciliation records, lack of documented release decisions, and insufficient linkage between activities performed and personnel responsible undermine the ability to demonstrate control of manufacturing and distribution processes.
4. Informal Management of Non-Compliances and Limited-Distribution Products
Issues identified in sample batches, promotional materials, or products with restricted distribution are often managed informally outside the Quality Management System. Failure to document deviations, assess regulatory impact, or apply structured CAPA processes weakens post-market surveillance and vigilance compliance under MDR.
5. Absence of Structured, Role-Based Training Programs
Many organizations do not maintain a formal training framework aligned with MDR requirements. Gaps commonly include undefined training curricula, lack of periodic refreshers, and insufficient coverage of regulatory obligations, GMP principles, and data protection requirements. This limits the organization’s ability to demonstrate sustained personnel competence.
6. Weak Data Governance and IT Access Controls
Despite increased regulatory focus on data integrity and confidentiality, data governance remains immature in many organizations. Common gaps include the absence of formal data protection policies, undocumented access management processes, and limited oversight of user access and audit trails. These weaknesses increase compliance and data integrity risks.
7. Insufficient Post-Market Surveillance and Safety Oversight
Audits frequently identify gaps in post-market surveillance systems, including unclear responsibilities for safety data collection, inadequate processes for managing adverse events, and limited monitoring of safety information from digital channels. Business continuity planning for safety activities is also often overlooked.
8. Organizational Governance and QA Independence Challenges
Unclear organizational structures, missing job descriptions, and overlapping operational and quality roles are commonly observed. When Quality Assurance functions lack independence or authority, effective oversight, escalation, and continuous improvement are compromised.
9. Ineffective Regulatory Communication and Change Management
Organizations often lack formal mechanisms to track regulatory notifications, registration changes, and authority communications. Without systematic processes to assess and communicate regulatory changes, there is an increased risk of delayed implementation or misalignment with MDR requirements.
Key Message
MDR compliance failures are rarely driven by single process gaps. They are typically the result of fragmented governance, insufficient integration of regulatory requirements into daily operations, and reliance on informal practices. Addressing these common pitfalls requires strengthening quality culture, embedding MDR expectations into core processes, and maintaining robust, well-documented systems that support traceability, accountability, and patient safety.
